BioLineRx (BLRX) Profit After Tax (QoQ) (2013 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | BioLineRx | 9.32 Bn | 9.30 Bn | 154,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -128.86% |
| Sep 30, 2025 | -124.80% |
| Jun 30, 2025 | -23.15% |
| Mar 31, 2025 | 260.87% |
| Dec 31, 2024 | 45.26% |
| Sep 30, 2024 | -1,302.89% |
| Jun 30, 2024 | 169.54% |
| Mar 31, 2024 | 94.99% |
| Dec 31, 2023 | 13.35% |
| Sep 30, 2023 | -186.40% |
| Jun 30, 2023 | 252.48% |
| Mar 31, 2023 | -112.21% |
| Dec 31, 2022 | 16.30% |
| Sep 30, 2022 | -191.99% |
| Jun 30, 2022 | 250.97% |
| Mar 31, 2022 | -14.54% |
| Dec 31, 2021 | 24.70% |
| Sep 30, 2021 | -183.54% |
| Jun 30, 2021 | 167.13% |
| Mar 31, 2021 | 14.98% |
| Dec 31, 2020 | -159.59% |
| Sep 30, 2020 | -168.21% |
| Jun 30, 2020 | 201.88% |
| Mar 31, 2020 | 32.66% |
| Dec 31, 2019 | -150.58% |
| Sep 30, 2019 | -171.80% |
| Jun 30, 2019 | 189.11% |
| Mar 31, 2019 | -8.90% |
| Dec 31, 2018 | 10.63% |
| Sep 30, 2018 | -232.08% |
| Jun 30, 2018 | 177.25% |
| Mar 31, 2018 | 15.75% |
| Dec 31, 2017 | -1.57% |
| Sep 30, 2017 | -247.91% |
| Jun 30, 2017 | 200.87% |
| Mar 31, 2017 | -13.30% |
| Dec 31, 2016 | 1.13% |
| Sep 30, 2016 | -16.04% |
| Jun 30, 2016 | -7.05% |
| Mar 31, 2016 | 4.46% |
| Dec 31, 2015 | -124.60% |
| Sep 30, 2015 | 66.20% |
| Jun 30, 2015 | -11.58% |
| Mar 31, 2015 | -2.81% |
| Dec 31, 2014 | -499.00% |
| Sep 30, 2014 | 82.79% |
| Jun 30, 2014 | -92.29% |
| Mar 31, 2014 | -6.71% |
| Dec 31, 2013 | 23.18% |
| Sep 30, 2013 | 31.98% |
| Jun 30, 2013 | -7.79% |